Your so-called assumptions are entirely consistent with my reaesrch.
Demand trends showed up in the last quarterly - and will be even more evident in the current quarter (as will be confirmed late Jan). Also apparent very large backlog in supply to distributors.
And the main thing - all this while one of the key products (oraline) is essentially off the market (until FDA clearance)
SBN Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held
